Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study explores impact of lymph node removal on mast cell tumours
The outlook for dogs with Kiupel high-grade cutaneous mast cell tumours has long been considered poor.

Researchers assess outcomes in dogs with Kiupel high-grade cutaneous MCTs.

The surgical removal and dissection of lymph nodes – or lymphadenectomy - significantly improves treatment outcomes for dogs with Kiepuel high-grade cutaneous mast cell tumours (MCTs), according to new research.

Published in the Journal of Small Animal Practice, the study found that lymphadenectomy – conducted as part of primary surgery alongside adjuvant therapy – significantly improves dogs' progression and survival time compared to dogs that do not undergo the procedure. 

'Lack of lymphadenectomy was the only variable significantly associated with a higher risk of nodal progression,' the authors conclude. 'Lymphadenectomy, along with the resection of the primary tumour and adjuvant medical treatment, improves outcome for dogs with Kiupel high-grade cutaneous mast cell tumours and overt nodal metastasis.'

The outlook for dogs with Kiupel high-grade cutaneous MCTs has long been considered poor. In more recent studies, however, the removal of metastatic regional lymph nodes has been linked to a better prognosis in canine cutaneous MCTs.

In the study, researchers compared 31 dogs that underwent lymphadenectomy with 18 dogs that did not undergo the procedure. They found that the average progression time was significantly shorter in dogs that did not undergo lymphadenectomy (150 days) compared to the other dogs (229 days). 

The collaborative study was conducted by researchers at the Universities of Bologna and Liverpool together with two Italian veterinary practices - Centro Veterinario Torinese, Turin, and Clinica Veterinaria Tibaldi, Milan.

JSAP editor Nicola Di Girolamo, said “It is really encouraging to see collaborations from multiple institutions like the study presented here. Including multiple institutions in a retrospective cohort study, does not only ensure a higher sample size but also ensures a higher generalisability of the results. 

“Meaning that it is more likely that the differences observed in this study are also going to be observed at different practices and with different clinicians.” 

Image © Gerry Polton Companion 2008.

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'